Daniel Buser - 30 Years of Guided Bone Regeneration

12.Qiu S, Rao DS, Palnitkar S, Parfitt AM. Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone 2002;31:709–711.

13.Ferretti M, Muglia MA, Remaggi F, Canè V, Palumbo C. Histomorphometric study on the osteocyte lacuno-canalicular network in animals of different species. II. Parallel-fibered and lamellar bones. Ital J Anat Embryol 1999;104:121–131.

14.Ham AW. Some histophysiological problems peculiar to calcified tissues. J Bone Joint Surg Am 1952;24 A:701–728.

15.Bonewald LF. The amazing osteocyte. J Bone Miner Res 2011;26:229–238.

16.Noble BS, Reeve J. Osteocyte function, osteocyte death and bone fracture resistance. Mol Cell Endocrinol 2000;159:7–13.

17.van Bezooijen RL, Roelen BA, Visser A, et al. Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004;199:805–814.

18.Xiong J, Piemontese M, Onal M, et al. Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone. PLoS One 2015;10:e0138189.

19.Jones SJ, Boyde A. Scanning electron microscopy of bone cells in culture. In: Copp DH, Talmage RV (eds). Endocrinology of Calcium Metabolism (Proceedings of the Sixth Parathyroid Conference 1977). Amsterdam: Excerpta Medica, 1978:97–104.

20.Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003;4:638–649.

21.Minkin C. Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285–290.

22.Nanci A. Content and distribution of noncollagenous matrix proteins in bone and cementum: Relationship to speed of formation and collagen packing density. J Struct Biol 1999;126:256–269.

23.Robey PG. Vertebrate mineralized matrix proteins: Structure and function. Connect Tissue Res 1996;35:131–136.

24.Sodek J, McKee MD. Molecular and cellular biology of alveolar bone. Periodontol 2000 2000;24:99–126.

25.Bosshardt DD. Are cementoblasts a subpopulation of osteoblasts or a unique phenotype? J Dent Res 2005;84:390–406.

26.Lamoureux F, Baud’huin M, Duplomb L, Heymann D, Rédini F. Proteoglycans: Key partners in bone cell biology. Bioessays 2007;29:758–771.

27.Butler WT. Noncollagenous proteins of bone and dentin: A brief overwiew. In: Goldberg M, Boskey A, Robinson C (eds). Chemistry and Biology of Mineralized Tissues: Proceedings of the Sixth International Conference, Vittel, France. Rosement: American Academy of Orthopedic Surgeons, 2000:137–141.

28.Hay ED. Collagen and other matrix glycoproteins in embryogenesis. In: Hay ED (ed). Cell Biology of Extracellular Matrix. New York: Plenum Press, 1991:437–444.

29.Christoffersen J, Landis WJ. A contribution with review to the description of mineralization of bone and other calcified tissues in vivo. Anat Rec 1991;230:435–450.

30.Enlow DH. Functions of the Haversian system. Am J Anat 1962;110:269–305.

31.Jaworski ZF, Lok E. The rate of osteoclastic bone erosion in Haversian remodeling sites of adult dog’s rib. Calcif Tissue Res 1972;10:103–112.

32.Schenk R, Willenegger H. Morphological findings in primary fracture healing. In: Krompecher S, Kerner E, (eds). Callus Formation: Symposium on the Biology of Fracture Healing, 1967:75–86.

33.Schenk RK. Cytodynamics and histodynamics of primary bone repair. In: Lane JM (ed). Fracture Healing. Edinburgh: Churchill Livingstone, 1987:23–32.

34.Wolff J. Das Gesetz der Transformation der Knochen. Berlin: Hirschwalk, 1892.

35.Suda T, Nakamura I, Jimi E, Takahashi N. Regulation of osteoclast function. J Bone Miner Res 1997;12:869–879.

36.Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004;83:166–169.

37.Aubin JE. Regulation of osteoblast formation and function. Rev Endocr Metab Disord 2001;2:81–94.

38.Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349–355.

39.Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl) 2001;79:243–253.

40.Goldring SR. Inflammatory mediators as essential elements in bone remodeling. Calcif Tissue Int 2003;73:97–100.

41.Clowes JA, Riggs BL, Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 2005;208:207–227.

42.Reddi AH. Cell biology and biochemistry of endochondral bone development. Coll Relat Res 1981;1:209–226.

43.Johner R. Dependence of bone healing on defect size [in German]. Helv Chir Acta 1972;39:409–411.

44.Harris WH, White RE, Jr, McCarthy JC, Walker PS, Weinberg EH. Bony ingrowth fixation of the acetabular component in canine hip joint arthroplasty. Clin Orthop Relat Res 1983;(176):7–11.

45.Berglundh T, Abrahamsson I, Lang NP, Lindhe J. De novo alveolar bone formation adjacent to endosseous implants. Clin Oral Implants Res 2003;14:251–262.

46.Abrahamsson I, Berglundh T, Linder E, Lang NP, Lindhe J. Early bone formation adjacent to rough and turned endosseous implant surfaces. An experimental study in the dog. Clin Oral Implants Res 2004;15:381–392.

47.Buser D, Broggini N, Wieland M, et al. Enhanced bone apposition to a chemically modified SLA titanium surface. J Dent Res 2004;83:529–533.

48.Bosshardt DD, Chappuis V, Buser D. Osseointegration of titanium, titanium alloy and zirconia dental implants: Current knowledge and open questions. Periodontol 2000 2017;73:22–40.

49.Nyman S, Lindhe J, Karring T, Rylander H. New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 1982;9:290–296.

50.Nyman S, Gottlow J, Karring T, Lindhe J. The regenerative potential of the periodontal ligament. An experimental study in the monkey. J Clin Periodontol 1982;9:257–265.

51.Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by guided tissue regeneration. Plast Reconstr Surg 1988;81:672–676.

52.Dahlin C, Sennerby L, Lekholm U, Linde A, Nyman S. Generation of new bone around titanium implants using a membrane technique: An experimental study in rabbits. Int J Oral Maxillofac Implants 1989;4:19–25.

53.Dahlin C, Gottlow J, Linde A, Nyman S. Healing of maxillary and mandibular bone defects using a membrane technique. An experimental study in monkeys. Scand J Plast Reconstr Surg Hand Surg 1990;24:13–19.

54.Boyne PJ. Restoration of osseous defects in maxillofacial casualities. J Am Dent Assoc 1969;78:767–776.

55.Hardwick R, Scantlebury TV, Sanchez R, Whitley N, Armbruster J. Membrane design criteria for guided bone regeneration of the alveolar ridge. In: Buser D, Dahlin C, Schenk RK (eds). Guided Bone Regeneration in Implant Dentistry. Chicago: Quintessence, 1994:101–136.

56.Zellin G, Linde A. Effects of different osteopromotive membrane porosities on experimental bone neogenesis in rats. Biomaterials 1996;17:695–702.

57.Wikesjö UME, Lim WH, Thomson RC, Hardwick WR. Periodontal repair in dogs: Gingival tissue occlusion, a critical requirement for GTR? J Clin Periodontol 2003;30:655–664.

58.Omar O, Elgali I, Dahlin C, Thomsen P. Barrier membranes: More than the barrier effect? J Clin Periodontol 2019;46(suppl 21):103–123.

59.Bornstein MM, von Arx T, Bosshardt DD. Properties of barrier membranes. In: Buser D,(ed). 20 Years of Guided Bone Regeneration. Chicago: Quintessence, 2009:47–69.

60.Elgali I, Omar O, Dahlin C, Thomsen P. Guided bone regeneration: Materials and biological mechanisms revisited. Eur J Oral Sci 2017;125:315–337.

61.Winet H, Hollinger JO. Incorporation of polylactide-polyglycolide in a cortical defect: Neoosteogenesis in a bone chamber. J Biomed Mater Res 1993;27:667–676.